Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
-
Published:2022-04-09
Issue:3
Volume:16
Page:691-701
-
ISSN:1936-0533
-
Container-title:Hepatology International
-
language:en
-
Short-container-title:Hepatol Int
Author:
Wang Jitao, Zhang Qiran, Ai Jingwen, Liu Dengxiang, Liu Chuan, Xiang Huiling, Gu Ye, Guo Ying, Lv Jiaojian, Huang Yifei, Liu Yanna, Xu Dan, Chen Shubo, Li Jinlong, Li Qianqian, Liang Jing, Bian Li, Zhang Zhen, Guo Xiaoqing, Feng Yinong, Liu Luxiang, Zhang Xuying, Zhang Yanliang, Xie Faren, Jiang Shujun, Qin Wei, Wang Xiaodong, Rao Wei, Zhang Qun, Tian Qiuju, Zhu Ying, Cong Qingwei, Xu Juan, Hou Zhiyun, Zhang Nina, Zhang Aiguo, Zu Hongmei, Wang Yun, Yan Zhaolan, Du Xiufang, Hou Aifang, Yan Yan, Qiu Yuanwang, Wu Hangyuan, Hu Shengjuan, Deng Yanhong, Ji Jiansong, Yang Jie, Huang Jiansheng, Zhao Zhongwei, Zou Shengqiang, Ji Hailei, Ge Guohong, Zhong Li, He Song, Yan Xiaosong, Yangzhen Bian Ba, Qu Ci, Zhang Liting, Yang Shiying, Gao Xiaoqin, Lv Muhan, Zhu Qingliang, Xu Xinxin, Zeng Qing-Lei, Qi XiaolongORCID, Zhang Wenhong
Funder
Gansu Science Fund for Distinguished Young Scholars
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Cornberg M, Buti M, Eberhardt CS, Grossi PA, Shouval D. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients. J Hepatol. 2021;74(4):944–951 2. Marjot T, Webb GJ, Barritt AS, et al. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol. 2021;18(5):348–364 3. Fix OK, Blumberg EA, Chang KM, et al. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease. Hepatology. 2021;74(2):1049–1064 4. Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615 5. Xia S, Duan K, Zhang Y, et al. Effect of an Inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials. JAMA. 2020;324(10):951–960
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|